Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Apilimod mesilate has limited efficacy in phase II trial in rheumatoid arthritis

Nov. 22, 2010

Proof-of-concept secukinumab trial in ankylosing spondylitis meets primary endpoint

Nov. 19, 2010

AC-430 confers protection in models of autoimmune and inflammatory conditions

Nov. 19, 2010

EVX-001650 displays antipsychotic activity in mouse models related to schizophrenia

Nov. 19, 2010

Clinical development of ChimeriVax-Dengue vaccine updated

Nov. 19, 2010

Typhoid fever vaccine Vi-TT is safe in pediatric and juvenile subjects

Nov. 18, 2010

Switch pocket kinase inhibitors DP-4610, DP-3556 and DP-4178 show promise in models of RA

Nov. 18, 2010

Phase I data support safety and preliminary activity of MLTA3698A in active RA

Nov. 18, 2010

PET tracer [11C]-NS-14492 can visualize in vivo occupancy of nicotinic acetylcholine alpha7 receptor

Nov. 18, 2010

BSAM-2/Alhydrogel/CPG-7909 vaccine enters clinical evaluation in malaria-naive adults

Nov. 18, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...